Report #2831786

Received Mar 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

ChillsNausea

Symptom narrative

Chills; nausea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced chills (Verbatim: Chills) and nausea (Verbatim: nausea). The outcome of the chills and nausea were not reported. It was unknown if the reporter considered the chills and nausea to be related to Shingrix. It was unknown if the company considered the chills and nausea to be related to Shingrix. Additional Information: GSK Receipt Date: 07-MAR-2025 This case was reported by a patient via (Shingrix GSK chat BOT) interactive digital media. The patient received Shingrix vaccine and experienced chills and nausea.